Mimi Ton
Pediatric Gastroenterology · Newark, NJNPI 1033178355
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 66 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 22.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $397, 2.8 times the $140 reported in 2019.
Across 66 payments — averaging $21.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mirum Pharmaceuticals, Inc.$323
- AbbVie$120
- Biomarin Pharmaceutical Inc.$108
- Coloplast$97
- Ipsen Biopharmaceuticals, Inc$74
- GSK$64
- plus $659 from 24 others
What the payments were for
- Food & beverage$1,444100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mirum Pharmaceuticals, Inc. | 4 | $323 |
| AbbVie | 9 | $120 |
| Biomarin Pharmaceutical Inc. | 5 | $108 |
| Coloplast | 1 | $97 |
| Ipsen Biopharmaceuticals, Inc | 4 | $74 |
| GSK | 4 | $64 |
| Travere Therapeutics, Inc. | 3 | $60 |
| Sanofi | 3 | $58 |
| Johnson & Johnson | 3 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $39 |
| AstraZeneca | 2 | $36 |
| Kyowa Kirin, Inc. | 2 | $35 |
| Amgen | 1 | $35 |
| Organon | 2 | $32 |
| Sandoz | 2 | $31 |
| Tolmar, Inc. | 2 | $31 |
| Nestle Healthcare Nutrition Inc. | 2 | $29 |
| Albireo Pharma, Inc. | 2 | $26 |
| Kadmon Pharmaceuticals LLC | 1 | $23 |
| Endo USA, Inc. | 1 | $19 |
| Azurity Pharmaceuticals, Inc. | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Neurocrine Biosciences, Inc. | 1 | $16 |
| BD | 1 | $16 |
| UCB, Inc. | 1 | $16 |
| Insulet Corporation | 1 | $15 |
| Bristol Myers Squibb | 1 | $15 |
| Neurelis, Inc. | 1 | $15 |
| Cumberland Pharmaceuticals, Inc. | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Livmarli$285
How this compares
$1,444 in reported general payments places this provider in the 85th percentile of 54 pediatric gastroenterology providers in New Jersey.
See all pediatric gastroenterology providers in New Jersey →
Other pediatric gastroenterology in Newark
- Elsie FoglioNewark$1K
- Iona MonteiroNewark$100
- Joel RoshMorristown$21K
- Rupinder GillNew Brunswick$6K
- Alycia LeibyMorristown$4K
- John TungCamden$3K
- Oren KosloweMorristown$2K
- Svetlana SabelWest Orange$2K
- Alexander SchosheimOcean$2K
- Ashwin AgrawalEatontown$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.